Concentric Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $8.39M | Sell |
26,025
-250
| -1% | -$81.8K | 2.05% | 12 |
|
|
2024
Q2 | $8.21M | Buy |
26,275
+337
| +1% | +$99K | 2.14% | 10 |
|
|
2024
Q1 | $7.37M | Buy |
25,938
+375
| +1% | +$110K | 1.96% | 15 |
|
|
2023
Q4 | $7.36M | Buy |
25,563
+87
| +0.3% | +$23.7K | 2.14% | 9 |
|
|
2023
Q3 | $6.85M | Buy |
25,476
+280
| +1% | +$69.9K | 2.26% | 11 |
|
|
2023
Q2 | $5.59M | Buy |
25,196
+1,050
| +4% | +$244K | 1.78% | 17 |
|
|
2023
Q1 | $5.84M | Buy |
24,146
+161
| +0.7% | +$39.5K | 1.93% | 14 |
|
|
2022
Q4 | $6.3M | Sell |
23,985
-1,218
| -5% | -$326K | 2.15% | 10 |
|
|
2022
Q3 | $5.68M | Buy |
25,203
+36
| +0.1% | +$8.73K | 2.09% | 11 |
|
|
2022
Q2 | $6.12M | Sell |
25,167
-116
| -0.5% | -$28.4K | 2.07% | 11 |
|
|
2022
Q1 | $6.11M | Buy |
25,283
+370
| +1% | +$85K | 1.77% | 14 |
|
|
2021
Q4 | $5.61M | Buy |
24,913
+705
| +3% | +$149K | 1.58% | 19 |
|
|
2021
Q3 | $5.15M | Buy |
24,208
+555
| +2% | +$128K | 1.57% | 18 |
|
|
2021
Q2 | $5.76M | Buy |
23,653
+669
| +3% | +$165K | 1.77% | 15 |
|
|
2021
Q1 | $5.72M | Buy |
22,984
+1,109
| +5% | +$265K | 1.89% | 14 |
|
|
2020
Q4 | $5.03M | Buy |
21,875
+340
| +2% | +$78.4K | 1.85% | 14 |
|
|
2020
Q3 | $5.47M | Buy |
21,535
+117
| +0.5% | +$29K | 2.36% | 9 |
|
|
2020
Q2 | $5.05M | Buy |
21,418
+240
| +1% | +$54.8K | 2.37% | 8 |
|
|
2020
Q1 | $4.29M | Buy |
21,178
+85
| +0.4% | +$18.6K | 2.38% | 8 |
|
|
2019
Q4 | $5.08M | Buy |
21,093
+7,009
| +50% | +$1.54M | 2.18% | 10 |
|
|
2019
Q3 | $2.73M | Buy |
14,084
+52
| +0.4% | +$9.98K | 1.73% | 22 |
|
|
2019
Q2 | $2.59M | Buy |
14,032
+485
| +4% | +$86.8K | 1.68% | 23 |
|
|
2019
Q1 | $2.57M | Buy |
13,547
+555
| +4% | +$106K | 1.74% | 23 |
|
|
2018
Q4 | $2.53M | Buy |
12,992
+890
| +7% | +$174K | 1.94% | 19 |
|
|
2018
Q3 | $2.51M | Sell |
12,102
-211
| -2% | -$41.6K | 1.76% | 21 |
|
|
2018
Q2 | $2.27M | Buy |
12,313
+610
| +5% | +$108K | 1.63% | 23 |
|
|
2018
Q1 | $2M | Buy |
11,703
+285
| +2% | +$52.3K | 1.48% | 30 |
|
|
2017
Q4 | $1.99M | Buy |
11,418
+338
| +3% | +$59.8K | 1.44% | 29 |
|
|
2017
Q3 | $2.07M | Buy |
11,080
+120
| +1% | +$21.3K | 1.57% | 25 |
|
|
2017
Q2 | $1.89M | Sell |
10,960
-123
| -1% | -$20K | 1.5% | 29 |
|
|
2017
Q1 | $1.82M | Buy |
11,083
+28
| +0.3% | +$4.65K | 1.48% | 30 |
|
|
2016
Q4 | $1.62M | Buy |
+11,055
| New | +$1.66M | 1.35% | 35 |
|
Other funds holding AMGN
Concentric Wealth Management's AMGN Position: Q3 2024 in Review
Concentric Wealth Management reduced its Amgen (AMGN) stake by 0.95% in Q3 2024, selling an estimated $81.8K and leaving 26,025 shares worth $8.39M. The position accounts for 2.05% of the portfolio, ranked #12.
Concentric Wealth Management first reported a position in AMGN in Q4 2016 and has held it in 32 quarters since. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.
- Concentric Wealth Management held 26,025 shares of Amgen worth $8.39M as of Q3 2024.
- Concentric Wealth Management sold 250 Amgen shares in Q3 2024, an estimated $81.8K.
- Amgen made up 2.05% of Concentric Wealth Management's portfolio in Q3 2024, its #12 holding.
- Concentric Wealth Management first reported a position in Amgen in Q4 2016 and has held it in 32 quarters since.
- 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.
Based on Concentric Wealth Management's 13F filing for Q3 2024, filed 13 Nov 2024.